Suppression of B-Raf^V600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone

References

• Sullivan RJ, Flaherty K. MAP kinase signaling and inhibition in melanoma. Oncogene 2013; 32:2373-9; PMID:22945644; http://dx.doi.org/10.1038/onc.2012.345
   PubMed Web of Science ®Google Scholar
• Sale MJ, Cook SJ. Intrinsic and acquired resistance to MEK1/2 inhibitors in cancer. Biochem Soc Trans 2014; 42:776-83; PMID:25109957; http://dx.doi.org/10.1042/BST20140129
   PubMed Web of Science ®Google Scholar
• Holderfield M, Deuker MM, McCormick F, McMahon M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer 2014; 14:455-67; PMID:24957944; http://dx.doi.org/10.1038/nrc3760
   PubMed Web of Science ®Google Scholar
• Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21:297-308; PMID:22439925; http://dx.doi.org/10.1016/j.ccr.2012.02.014
   PubMed Web of Science ®Google Scholar
• Don AS, Hogg PJ. Mitochondria as cancer drug targets. Trends Mol Med 2004; 10:372-8; PMID:15310457; http://dx.doi.org/10.1016/j.molmed.2004.06.005
   PubMed Web of Science ®Google Scholar
• Sarosiek KA, Ni Chonghaile T, Letai A. Mitochondria: gatekeepers of response to chemotherapy. Trends Cell Biol 2013; 23:612-9; PMID:24060597; http://dx.doi.org/10.1016/j.tcb.2013.08.003
   PubMed Web of Science ®Google Scholar
• Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 2014; 14:709-21; PMID:25342630; http://dx.doi.org/10.1038/nrc3803
   PubMed Web of Science ®Google Scholar
• Haq R, Fisher DE, Widlund HR. Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation. Clin Cancer Res 2014; 20:2257-63; PMID:24610826; http://dx.doi.org/10.1158/1078-0432.CCR-13-0898
   PubMed Web of Science ®Google Scholar
• Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM, et al. PGC1alpha Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress. Cancer Cell 2013; 23:287-301; PMID:23416000; http://dx.doi.org/10.1016/j.ccr.2012.11.020
   PubMed Web of Science ®Google Scholar
• Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL, et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 2013; 23:302-15; PMID:23477830; http://dx.doi.org/10.1016/j.ccr.2013.02.003
   PubMed Web of Science ®Google Scholar
• Millard M, Pathania D, Shabaik Y, Taheri L, Deng J, Neamati N. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One 2010; 5:e13131; PMID:20957228; http://dx.doi.org/10.1371/journal.pone.0013131
   Web of Science ®Google Scholar
• Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007; 47:629-56; PMID:17014364; http://dx.doi.org/10.1146/annurev.pharmtox.47.120505.105110
   PubMed Web of Science ®Google Scholar
• Smith RA, Adlam VJ, Blaikie FH, Manas AR, Porteous CM, James AM, Ross MF, Logan A, Cochemé HM, Trnka J, et al. Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 2008; 1147:105-11; PMID:19076435; http://dx.doi.org/10.1196/annals.1427.003
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano JS, Aprille JR. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev 2001; 49:63-70; PMID:11377803; http://dx.doi.org/10.1016/S0169-409X(01)00125-9
   PubMed Web of Science ®Google Scholar
• Starenki D, Park JI. Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo. J Clin Endocrinol Metab 2013; 98:1529-40; PMID:23509102; http://dx.doi.org/10.1210/jc.2012-3671
   PubMed Web of Science ®Google Scholar
• Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC, Jr., Joseph J, Kalyanaraman B. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res 2012; 72:2634-44; PMID:22431711; http://dx.doi.org/10.1158/0008-5472.CAN-11-3928
   PubMed Web of Science ®Google Scholar
• Girotti MR, Pedersen M, Sanchez-Laorden B, Viros A, Turajlic S, Niculescu-Duvaz D, Zambon A, Sinclair J, Hayes A, Gore M, et al. Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma. Cancer Discov 2013; 3:158-67; PMID:23242808; http://dx.doi.org/10.1158/2159-8290.CD-12-0386
   PubMed Web of Science ®Google Scholar
• Dhanasekaran A, Kotamraju S, Karunakaran C, Kalivendi SV, Thomas S, Joseph J, Kalyanaraman B. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic Biol Med 2005; 39:567-83; PMID:16085176; http://dx.doi.org/10.1016/j.freeradbiomed.2005.04.016
   PubMed Web of Science ®Google Scholar
• Wu PK, Hong SK, Veeranki S, Karkhanis M, Starenki D, Plaza JA, Park JI. A Mortalin/HSPA9-Mediated Switch in Tumor-Suppressive Signaling of Raf/MEK/Extracellular Signal-Regulated Kinase. Mol Cell Biol 2013; 33:4051-67; PMID:23959801; http://dx.doi.org/10.1128/MCB.00021-13
   PubMed Web of Science ®Google Scholar
• Starenki D, Hong SK, Lloyd RV, Park JI. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Oncogene 2015; 34:4624-34; PMID:25435367; http://dx.doi.org/10.1038/onc.2014.392
   PubMed Web of Science ®Google Scholar
• Starenki D, Park JI. Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro And In Vivo. Endocrinol Metab (Seoul) 2015; 30:593-603; PMID:26485469
   PubMedGoogle Scholar
• Hong SK, Yoon S, Moelling C, Arthan D, Park JI. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem 2009; 284:33006-18; PMID:19805545; http://dx.doi.org/10.1074/jbc.M109.012591
   PubMed Web of Science ®Google Scholar
• Rosen A, Casciola-Rosen L. Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 1997; 64:50-4; PMID:9015754; http://dx.doi.org/10.1002/(SICI)1097-4644(199701)64:1%3c50::AID-JCB8%3e3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Lin TK, Hughes G, Muratovska A, Blaikie FH, Brookes PS, Darley-Usmar V, Smith RA, Murphy MP. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J Biol Chem 2002; 277:17048-56; PMID:11861642; http://dx.doi.org/10.1074/jbc.M110797200
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12; PMID:9721092; http://dx.doi.org/10.1126/science.281.5381.1309
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401:1-11; PMID:17150040; http://dx.doi.org/10.1042/BJ20061131
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B. Oxidative chemistry of fluorescent dyes: implications in the detection of reactive oxygen and nitrogen species. Biochem Soc Trans 2011; 39:1221-5; PMID:21936793; http://dx.doi.org/10.1042/BST0391221
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Mitochondrial gateways to cancer. Mol Aspects Med 2010; 31:1-20; PMID:19698742; http://dx.doi.org/10.1016/j.mam.2009.08.002
   PubMed Web of Science ®Google Scholar
• Krishna MC, Russo A, Mitchell JB, Goldstein S, Dafni H, Samuni A. Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem 1996; 271:26026-31; PMID:8824242; http://dx.doi.org/10.1074/jbc.271.42.26026
   PubMed Web of Science ®Google Scholar
• Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, Joseph J, Kalyanaraman B. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem 2004; 279:37575-87; PMID:15220329; http://dx.doi.org/10.1074/jbc.M404003200
   PubMed Web of Science ®Google Scholar
• Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 2012; 1826:443-57; PMID:22728050; http://dx.doi.org/10.1016/j.bbcan.2012.06.003
   PubMed Web of Science ®Google Scholar